Pipex Pharmaceuticals (PP) Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer
Pipex Pharmaceuticals, Inc. (AMEX: PP) recently announced that Nicholas Stergis, co-founder and vice chairman of the board of directors, has joined the executive management team as chief executive officer, replacing Steve H. Kanzer who will continue to serve as the company’s chairman. In addition, the company announced the resignations of Daniel J. Dorman, a director, and Dr. Charles L. Bisgaier, Pipex's president, effective immediately. As an original co-founder of Pipex Therapeutics, Inc., the predecessor company, Mr. Stergis has been vice chairman of the company’s board of directors since March 2007. He has also served as Pipex’s chief operating officer from…